Skip to content

Blood Collection for Research Related to Certain Diseases Involving Blood Vessels

Human Specimen Collection to Support Basic and Clinical Research

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00047996
Enrollment
2000
Registered
2002-10-23
Start date
2002-11-04
Completion date
Unknown
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sickle Cell Disease

Keywords

DNA, Endothelial Function, Leukocyte Gene Expression, RNA, Natural History, Sickle Cell, Coronary Artery Disease, CAD, Healthy Volunteer, HV

Brief summary

The collection of human specimens from both patients and healthy volunteers is necessary for the development of laboratory assays to further basic and clinical research studies. This protocol defines the purposes for which specimens will be collected and establishes general conditions under which sample collection will be performed....

Detailed description

The collection of human specimens from both patients and healthy volunteers is necessary for the development of laboratory assays to further basic and clinical research studies. This protocol defines the purposes for which specimens will be collected and establishes general conditions under which sample collection will be performed.

Interventions

None listed

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
Lead SponsorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* INCLUSION CRITERIA: Males or females of age 18 years and older can be included in the study.

Exclusion criteria

Individuals without sickle cell disease or other chronic anemias who wish to donate blood will be excluded if the hemoglobin is less than 10 g/dL for women or less than 12g/dL for men. Individuals with sickle cell disease or other chronic anemias will be excluded from donating blood samples if the hemoglobin is less than 6 g/dL. A participant s most recent CBC result, obtained in the past 12 months, will be used to determine eligibility. There are no

Design outcomes

Primary

MeasureTime frame
evaluating the role of nitric oxide, inflammatory mediators, and endothelial function in inflammatory diseases of the vasculature such as sickle cell disease, coronary artery disease, pulmonary vascular or advanced lung disease, malaria, and sep...

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORSwee Lay Thein, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026